---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-046528"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T00:57:00.637359+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# InMed appoints Nicole Lemerond to board; Adam Cutler resigns

## Summary
- Adam Cutler resigned from board effective Aug 8, 2022; no disagreement with the company.
- Nicole Lemerond appointed to board effective Aug 8, 2022; fills vacancy on Audit and Governance Committees.
- Ms. Lemerond has 25+ years in investment management, private equity, healthcare finance; CFA charterholder.
- Standard director compensation: $45,000 annual retainer plus options for 14,000 common shares.

## SEC filing metadata
- accession: 0001213900-22-046528
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/0001213900-22-046528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/ea164185-8k_inmedphar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-046528
- JSON: https://secwatch.observer/filing/0001213900-22-046528.json
- Plain text: https://secwatch.observer/filing/0001213900-22-046528.txt

## Key facts
- Executive change
  Nicole Lemerond was appointed as Director at InMed Pharmaceuticals Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Nicole Lemerond as a director of the Board to fill the vacancy created by Mr. Cutler’s resignation, effective as of August 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/0001213900-22-046528-index.htm
- Executive change
  Adam Cutler resigned as Director at InMed Pharmaceuticals Inc..
  - Action: resigned
  - Role: Director
  source text: Adam Cutler resigned from the Board of Directors (the “Board”) (including from the Nominating & Corporate Governance Committee and the Audit Committee) of the Company, effective as of August 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/0001213900-22-046528-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.